New Zealand markets closed
  • NZX 50

    10,753.16
    -115.54 (-1.06%)
     
  • NZD/USD

    0.6210
    -0.0035 (-0.55%)
     
  • NZD/EUR

    0.5948
    -0.0005 (-0.08%)
     
  • ALL ORDS

    6,720.40
    -26.10 (-0.39%)
     
  • ASX 200

    6,539.90
    -28.20 (-0.43%)
     
  • OIL

    108.46
    +2.70 (+2.55%)
     
  • GOLD

    1,812.90
    +5.60 (+0.31%)
     
  • NASDAQ

    11,585.68
    +81.96 (+0.71%)
     
  • FTSE

    7,168.65
    -0.63 (-0.01%)
     
  • Dow Jones

    31,097.26
    +321.83 (+1.05%)
     
  • DAX

    12,813.03
    +29.26 (+0.23%)
     
  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     
  • NZD/JPY

    83.9370
    -0.7780 (-0.92%)
     

Research Antibodies Market Research by Function, Operation, Product, Source, Technology, Type, End User - Global Forecast to 2027 - Biomarker Discovery Gaining Attractive Market Edge - ResearchAndMarkets.com

·5-min read

DUBLIN, May 23, 2022--(BUSINESS WIRE)--The "Research Antibodies Market Research Report by Function, Operation, Product, Source, Technology, Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Research Antibodies Market size was estimated at USD 13.61 billion in 2021, USD 14.58 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.32% to reach USD 20.80 billion by 2027.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Cumulative Impact of COVID-19:

The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Automotive Windshield Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.

It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

  • Abcam PLC

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • Biolegend, Inc.

  • Cell Signaling Technology, Inc.

  • Danaher Corporation

  • F. Hoffmann-La Roche AG

  • GenScript Corporation

  • Lonza Group

  • Merck Group

  • Perkin Elmer, Inc.

  • QIAGEN, Inc.

  • Sysmex Corporation

  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.1.1. Increasing research and development activity and funding

5.1.1.2. Increasing focus in Stem Cell and Neurobiology Research

5.1.1.3. Collaborations between industry and academics

5.1.2. Restraints

5.1.2.1. Time and cost consuming antibody development processes

5.1.3. Opportunities

5.1.3.1. Biomarker Discovery gaining attractive market edge

5.1.3.2. Increasing demand for Protein Therapeutics and Personalized Medicine

5.1.3.3. Growth prospects in emerging markets

5.1.4. Challenges

5.1.4.1. Quality concerns

5.1.4.2. Pricing pressure

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Research Antibodies Market, by Function

6.1. Introduction

6.2. Immunology

6.3. Infectious Diseases

6.4. Neurobiology

6.5. Oncology

6.6. Stem Cells

7. Research Antibodies Market, by Operation

7.1. Introduction

7.2. Drug Development

7.3. Genomics

7.4. Proteomics

8. Research Antibodies Market, by Product

8.1. Introduction

8.2. Monoclonal Antibodies

8.3. Polyclonal Antibodies

9. Research Antibodies Market, by Source

9.1. Introduction

9.2. Goat

9.3. Mouse

9.4. Rabbit

10. Research Antibodies Market, by Technology

10.1. Introduction

10.2. Enzyme-linked Immunosorbent Assay

10.3. Flow Cytometry

10.4. Immunofluorescence

10.5. Immunohistochemistry

10.6. Immunoprecipitation

10.7. Western Blotting

11. Research Antibodies Market, by Type

11.1. Introduction

11.2. Primary Antibodies

11.3. Secondary Antibodies

12. Research Antibodies Market, by End User

12.1. Introduction

12.2. Academic & Research Institutes

12.3. Pharmaceutical & Biotechnology Companies

13. Americas Research Antibodies Market

13.1. Introduction

13.2. Argentina

13.3. Brazil

13.4. Canada

13.5. Mexico

13.6. United States

14. Asia-Pacific Research Antibodies Market

14.1. Introduction

14.2. Australia

14.3. China

14.4. India

14.5. Indonesia

14.6. Japan

14.7. Malaysia

14.8. Philippines

14.9. Singapore

14.10. South Korea

14.11. Taiwan

14.12. Thailand

15. Europe, Middle East & Africa Research Antibodies Market

15.1. Introduction

15.2. France

15.3. Germany

15.4. Italy

15.5. Netherlands

15.6. Qatar

15.7. Russia

15.8. Saudi Arabia

15.9. South Africa

15.10. Spain

15.11. United Arab Emirates

15.12. United Kingdom

16. Competitive Landscape

16.1. FPNV Positioning Matrix

16.1.1. Quadrants

16.1.2. Business Strategy

16.1.3. Product Satisfaction

16.2. Market Ranking Analysis

16.3. Market Share Analysis, By Key Player

16.4. Competitive Scenario

16.4.1. Merger & Acquisition

16.4.2. Agreement, Collaboration, & Partnership

16.4.3. New Product Launch & Enhancement

16.4.4. Investment & Funding

16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles

For more information about this report visit https://www.researchandmarkets.com/r/34o5an

View source version on businesswire.com: https://www.businesswire.com/news/home/20220523005799/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting